Loading lessons…
Loading lessons…
Curated lessons across 8 learning paths — from first concepts to trial summaries and practical protocols. Pick your level, follow the curriculum, and build real understanding.
Where are you starting?
Choose a learning path below or search the library. Progress saves in your browser.
Prefer timeline chaos? Peptide X Quiz · Literacy certify
Pick a track — progress rings update as you complete lessons.
109 lessons
9mGHK-Cu is a small copper-binding peptide with decades of lab research and a thin human record. Here's what it is, why topical and injectable use are different questions, and where FDA stands in 2026.
9mRetatrutide is Lilly's investigational GIP, GLP-1 and glucagon receptor agonist. Understand the trial findings, how it differs from approved medicines, and why it is not available by prescription.
12mA goal-by-goal map of the peptides people ask about most, scored on human evidence and regulatory status. The only ones with strong evidence are approved drugs; most of the rest are animal data. No vendors, no dosing.
9mPeptide clinics outgrow spreadsheets at about the tenth patient. Here is a buyer's checklist for peptide therapy software: what the patient side has to do, what the staff side has to show, what to ask about security, and an honest description of what PeptIQ's provider console does and doesn't do.
9mTirzepatide is the dual GIP/GLP-1 receptor agonist behind Mounjaro (type 2 diabetes) and Zepbound (weight management, sleep apnea). Here's what it is, what the trials showed, how it compares with semaglutide and retatrutide, and how to get evaluated by a licensed clinician.
8mFoundayo is the brand name for orforglipron — a once-daily oral small-molecule GLP-1 approved in April 2026. Here's what the pill is, how it differs from injectables, and what trials studied — not a dosing prescription.
8mRotating injection sites is more than a diagram on a pamphlet. A simple journal helps you avoid repeat zones, spot irritation patterns, and share clean notes with your clinician.
8mSearching for a KLOW peptide dosage and frequency chart? Here's the blend math by label, how frequency discussions online differ from evidence, and how to log a four-component vial — without dosing advice.
10mSS-31 and MOTS-c sit at the intersection of mitochondria and metabolism hype. Separate published human research from forum dosing before you track either compound.
9mStacks multiply unknowns. Use this checklist to hand your clinician a complete concurrent-compound list before adding another vial to the protocol.
8mA math-only chart for 30 mg, 40 mg and 60 mg retatrutide vials: concentration at 1, 2, 3 and 5 mL of bacteriostatic water, mg per 10 units, and why bigger vials make unit errors more costly.
8m"Wolverine" is a nickname for BPC-157 plus TB-500. Here's what's in the blend, how the vial math works, how it compares with GLOW and KLOW, and how thin the human evidence still is.
9mSearch keeps landing on the same dosing pages. This listicle points you to the guides people actually use for MOTS-c, KLOW, SS-31, GHK-Cu, IGF-1 LR3, and retatrutide.
8mKLOW is a top PeptIQ page and a top search query. This guide ranks blend options, explains GLOW, and points to the deep dosing pages for each component.
8mRetatrutide owns PeptIQ's top blog slots. This listicle orders the beginner path: mix the vial, understand dosing, switch carefully, troubleshoot stalls, then consider stacks.
7mThe first small-molecule oral GLP-1 option removes injection training and cold-chain handling, but daily dosing creates a different adherence job.
8m5-Amino-1MQ dosage searches grew more than 1,400 percent. The stack page already ranks. This companion stays on milligram ranges and oral versus subQ handling language.
10mMost BPC-157 dose threads treat forum tables as fact. This guide separates published animal and limited human data from observational ranges people log, without turning either into a protocol.
10mCJC-1295 dose threads often ignore whether the vial is the albumin-binding DAC form or Mod GRF 1-29. The papers treat those as different exposure patterns. So should any educational chart.
9mEpitalon dose threads sell multi-day courses as if they were modern RCTs. The published record is older, smaller, and more specific than the calendars imply.
9mIpamorelin is discussed as a selective ghrelin-receptor secretagogue with a quieter side-effect story than older GHRPs. The papers describe pharmacology. Forum charts describe habits.
8mNAD+ 1000 mg reconstitution searches want a 1 g calculator. The existing NAD+ guide covers smaller vials. This page does the 1000 mg arithmetic and keeps it educational.
9mQueries about how much BAC water for a 20 mg retatrutide vial want a calculator. This page shows the arithmetic and why trial pens and unlabeled cakes are not the same object.
9mSermorelin is the short GHRH analog older clinic pages still treat as the gentle GH option. The literature is real. The nightly microgram charts are practice culture, not a modern phase 3 program.
10mTB-500 threads collapse a fragment, a parent peptide, and forum loading weeks into one chart. The papers are more specific, and the human dosing story is thinner than the marketing.
9mTesamorelin is one of the few GHRH analogs with an FDA-labeled daily milligram figure. That number belongs to a specific product and indication. It does not automatically travel to an unlabeled vial.
9mThymosin alpha-1 has a thicker clinical literature than most research-vial peptides. The milligram figures in those papers still belong to study and labeled-product contexts, not an unlabeled cake.
11mMid-40s and new to peptides? This guide explains how beginners typically choose a conservative first protocol using goals, compound class, published ranges, and tracking — without inventing a prescription.
12mKisspeptin-10 sits upstream of GnRH in reproductive endocrinology research. This guide explains mechanism, what people track, dosing as community discussion only, and why Kispeptin searches miss the mark.
10mDry powder vs mixed liquid changes everything — concentration, storage, and beyond-use timing. This guide explains lyophilized vs reconstituted peptides and what people mean by constituted vs non.
12mReta plus Tesa is one of the most asked stack questions in 2026. This guide explains why people combine metabolic and visceral-fat peptides, what to track, and why same-syringe mixing is usually avoided.
11mA 10 mg Selank vial looks simple until you mix the wrong diluent volume or chase a Sealink listing. This guide covers BAC reconstitution math, route context, and tracking habits — educational only, not medical advice.
9mAmycretin is Novo's dual GLP-1 + amylin molecule with both oral and injectable programs. Here's the early dosing map and why Phase 3 is the next SEO wave.
8mSame company family of ideas — GLP-1 + amylin — two product architectures. Here's how amycretin compares to CagriSema without fake head-to-head rankings.
8mCagrilintide is the amylin half of CagriSema. Here's the dosing map people actually search — 2.4 mg weekly combo context, monotherapy signal, and how not to cross-titrate with eloralintide.
8mCT-388 is Roche's weekly tirzepatide-class dual agonist with Phase 2 doses up to 24 mg. Here's the dosing vocabulary and the weight-loss signal searchers want.
8mSearching for eloralintide dosage? Here is the clean map of Phase 2 once-weekly doses, titration arms, and weight-loss results — framed as clinical education, not a DIY protocol.
8mAmylin + incretin is the stacking thesis behind CagriSema — and now eloralintide. Here's the clinical logic for combining pathways, without turning investigational drugs into DIY stacks.
8mPeople searching how to reconstitute eloralintide usually want a retatrutide-style BAC water chart. Here's the honest version — clinical weekly product vs unverified research powder.
7mAmylin agonists can feel GLP-1-like in the gut. Here's how to think about eloralintide tolerability, escalation, and symptom tracking without turning trial data into fear content.
7mWeekly amylin agonists are not MOTS-c. Here's when to inject eloralintide for tolerability — dose-day meals, evening vs morning, and what to log.
6mMacupatide is the Lilly code name beside eloralintide that most people skip. This beginner guide explains what it is — and what not to invent about dosing yet.
8mMariTide is Amgen's once-monthly obesity candidate. This beginner guide covers the mechanism framing, Phase 2 headlines, and what serious trackers should log.
9mMariTide is the once-monthly obesity candidate people keep comparing to weekly GLP-1s. Here's the Phase 2 dosing map — 140 / 280 / 420 mg and the escalation arms that mattered for tolerability.
8mWeekly vs monthly is the real MariTide comparison. Here's how Amgen's conjugate stacks up conceptually against weekly dual/triple agonists — without fake head-to-heads.
7mMazdutide is a once-weekly glucagon/GLP-1 dual agonist with clear Phase 3 dose anchors at 4 mg and 6 mg. Here's the dosing and results map searchers want.
8mOrforglipron is Lilly's once-daily oral small-molecule GLP-1. Here's the titration ladder searchers want — 1 mg start, step-ups every four weeks, and Phase 3 maintenance doses.
8mPetrelintide is the Roche/Zealand once-weekly amylin analog drawing GLP-1-level attention for tolerability. Here's the Phase 2 dosing pattern, results, and what to track.
8mSS-31 dosage searches keep climbing alongside MOTS-c. Here's the practical elamipretide dosing map — daily mg ranges, timing, cycling, and what to track for mitochondrial protocols.
8mSurvodutide is Boehringer's glucagon/GLP-1 dual agonist. Here's the dosing map from dose-finding through Phase 3 — weekly mg ranges, escalation logic, and what the weight-loss data showed.
Appetite control is useful only if it does not turn into under-eating. Track the right signals early so the scale does not hide the real tradeoffs.
8mThe next metabolic peptide wave is not just stronger GLP-1 dosing. Amylin, GIP, glucagon, and combination protocols are changing what serious tracking should include.
7mA 2025 Biomolecules review highlights the hardest GLP-1 question: what happens after the weight comes off? Maintenance needs a plan before the final dose.
7mAMA and FDA updates make one thing clear: peptide interest is moving faster than human evidence, dosing standards, and product-quality controls. Use this checklist before trusting a vial.
8mStack stories spread fast because they are visual and emotional. The smarter move is not to copy the protocol. It is to ask better evidence questions.
5mEducational reconstitution math for NAD+ vials: how diluent volume changes concentration, with worked examples that are not a universal mix or dosing protocol.
8mYou got your first peptide vials and now you are staring at two bottles of powder and a box of needles. Here is exactly how to mix BPC-157 and TB-500 without overthinking it.
11mBPC-157 and TB-500 are the most researched peptides for connective tissue repair—but combining them requires understanding their different mechanisms. Here's the complete stacking protocol based on actual user experience.
7mMOTS-C has a real adjustment period. Here's why weeks 1-2 can feel rough, when the energy kick in, and how to maximize the transition.
8mMOTS-C timing affects AMPK activation and metabolic benefits. Learn whether to take it fasted, how long to wait before eating, and how to optimize timing for AM or PM training schedules.
8mFour to six weeks on Retatrutide with a flat scale is common. Audit dose, intake, measurements, and product handling before you assume the peptide failed.
8mFinished your GLP-1 cycle and want to maintain metabolic momentum? MOTS-C is one of the most effective peptides for supporting fat oxidation and energy during GLP-1 off-cycles. Here's how to dose and time it.
8mThe MOTS-C dosing debate is real: 0.5-1mg daily vs 5mg 2-3x weekly. Both protocols have their advocates. Here's what the research says, why context matters, and how to choose the right approach for your situation.
9mAlready on Reta and ready to add compounds? Here's how to stack Tesamorelin and MOTS-C with Retatrutide for maximum fat loss and recomp.
9mAlready on tirzepatide and considering retatrutide? Here's exactly how to make the switch—starting doses based on your current Tirz level, what the glucagon component changes, and how to avoid common transition mistakes.
7mGrok says subQ Cerebrolysin doesn't work due to volumes. The real answer is more nuanced — and subQ is viable at research doses if you use the right solvent.
9mRunning Retatrutide and wondering what to add? This guide breaks down how MOTS-C, SS-31, AOD-9604, and SLU-PP-332 layer onto a GLP-1 protocol — and why they're not redundant.
10m5-Amino-1MQ blocks NNMT instead of suppressing appetite. This guide covers oral dosing ranges and why people stack it with GLP-1s and MOTS-C for stubborn visceral fat.
6mBAC water works for most peptides. Acetic acid is for hydrophobic compounds that won't dissolve in BAC. Sterile water only for certain compounds like Cerebrolysin. Here's how to choose and troubleshoot.
8mMOTS-C is mitochondria-encoded and activates AMPK through a pathway that's less prone to classic receptor downregulation. Here's how to structure long-term use for sustained results.
9mMost peptide users eventually ask: BAC or sterile water? This guide breaks down tradeoffs, timing, and practical decision rules with a peptide-by-peptide reference workflow.
9m87.5% of patients with chronic knee pain reported significant relief after BPC-157 treatment at the 6–12 month follow-up. Here's a breakdown of the human trial data, the dosing protocol used, and why this peptide is getting serious clinical attention.
10mBPC-157 and TB-500 are the two most evidence-backed peptides for structural tissue repair. For herniated disc recovery, they work through complementary pathways — here's how to stack them, dose them, and phase in the rest of a recovery protocol.
9mCJC-1295 with DAC lasts ~6–8 days (weekly pins). Without DAC (Mod GRF 1-29) lasts ~30 minutes and needs co-injection with Ipamorelin. Comparison table, doses, and which to pick.
8mMost people who take NAD+ daily wonder whether they should cycle it. The answer isn't black and white — it depends on your dose, delivery method, and goals. Here's what the research and community experience actually suggest.
8mAOD-9604 is a synthetic fragment of human growth hormone designed specifically to stimulate fat breakdown without the glucose or IGF-1 side effects of full HGH. Here's how it works and who it's for.
8mEpithalon is one of the most researched longevity peptides in existence, with decades of clinical data behind it. This guide covers the science of telomere elongation, dosing options, cycling protocols, and how it fits into a modern anti-aging stack.
10mMost peptide guides are written with a 35-year-old man in mind. If you're a woman in your 40s or 50s lifting hard and trying to recomp, the stack looks different. Here's what the research actually supports.
9mIGF-1 LR3 is one of the most potent muscle-building peptides available — but it's also one of the most commonly misdosed. Here's how to actually run it.
9mTesamorelin is an FDA-approved GHRH analog with clinical trials proving 15–20% visceral fat reduction. Here's the full science, dosing guide, and what the latest research reveals about its longevity applications.
9mCJC-1295 and Ipamorelin are two of the most popular GH secretagogues used together. This guide explains the differences between CJC with DAC and without DAC, how to dose them, and how to build the right protocol for your goals.
9mCerebrolysin is a brain-derived peptide mixture used for neuroprotection and cognitive enhancement. Here's what the research says, how to reconstitute it, and what real protocols look like.
8mIGF-1 LR3 and HGH are often grouped together, but they act at different points in the GH/IGF-1 axis. Here is the protocol-level breakdown for clinicians, athletes, and longevity-focused users.
7mMOTS-C is one of the most studied mitochondrial peptides for metabolic health and longevity. This guide covers dosing ranges, frequency, timing, stacking options, and what to track on protocol.
8mA complete breakdown of Dihexa — mechanism of action, dosing, what users actually report, and how it compares to Semax and Selank for cognitive enhancement.
6mOne of the most common beginner questions: can you draw multiple peptides into the same syringe? The answer depends on the combination. Here's the complete guide.
8mBoth MOTS-C and GHK-Cu are popular among serious lifters over 50 — but they work through completely different mechanisms. Here's how to choose, and why the best answer is often both.
10mThe biggest risk with GLP-1 weight loss drugs isn't the fat loss — it's the muscle you lose with it. Strategic peptide stacking can tip the balance toward true body recomposition.
9mEverything you need to know before your first retatrutide injection — reconstitution math, dose calculations, injection technique, and what to expect if you have prior GLP-1 sensitivity.
7mGHK-Cu is one of the most researched anti-aging peptides available. Here's a practical dosing guide covering protocols, cycle length, stacking, and what to realistically expect.
8mReconstituting peptides is simpler than it looks. This guide walks you through every step — from choosing the right BAC water volume to calculating units on your insulin syringe.
9mBPC-157 accelerates tissue repair by stimulating angiogenesis and collagen synthesis. Here's what the research shows and what users need to know.
9mMOTS-C is the first peptide found encoded in mitochondrial DNA. It activates AMPK, mimics exercise-induced metabolic adaptations, and may be one of the most powerful tools for metabolic optimization available.
12mRetatrutide is Lilly's investigational GIP/GLP-1/glucagon triple agonist. This hub covers what it is, what the trials actually reported about dosing and weight loss, how vial math works, where approval stands, and links to every retatrutide guide on PeptIQ.io.
10mRetatrutide is a next-generation weight loss peptide targeting three metabolic pathways. Here's how it works and why it outperforms earlier GLP-1 therapies.
12mBPC-157 shows promise in clinical research for accelerating tendon repair and recovery. Learn how this peptide works and what the science says about its efficacy.
12mBPC-157 is the most versatile healing peptide available. Here's how it works and how to use it effectively.
10mThe complete guide to safely reconstituting peptides, including dosage calculations and best practices.
12mExplore the healing peptide BPC-157, nicknamed the 'Wolverine peptide' for its remarkable regenerative properties.
10mDiscover how TB-500 promotes tissue repair, reduces inflammation, and supports recovery from injuries.
9mExplore why Ipamorelin is considered the gentlest yet effective growth hormone releasing peptide available.
8mLearn where and how to inject peptides safely with our comprehensive injection site guide and rotation protocol.
9mLearn why Sermorelin is a popular choice for natural GH optimization and anti-aging protocols.
11mExplore how Semaglutide has revolutionized weight management through GLP-1 receptor agonism.
11mDiscover which peptides work synergistically together and how to stack them safely for enhanced benefits.
7mUnderstand why bacteriostatic water is essential for peptide reconstitution and how to use it properly.
9mLearn about Melanotan 2, the peptide that stimulates melanin production for UV-free tanning effects.
8mDiscover how AOD-9604 targets fat metabolism specifically, offering a focused approach to body composition.
8mUnderstand the science of peptide cycling and how to structure breaks for optimal long-term results.
Also available at /blog for legacy links.